HK1206277A1 - Isolation and use of human lymphoid organ-derived suppressive stromal cells - Google Patents
Isolation and use of human lymphoid organ-derived suppressive stromal cellsInfo
- Publication number
- HK1206277A1 HK1206277A1 HK15107022.0A HK15107022A HK1206277A1 HK 1206277 A1 HK1206277 A1 HK 1206277A1 HK 15107022 A HK15107022 A HK 15107022A HK 1206277 A1 HK1206277 A1 HK 1206277A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- isolation
- stromal cells
- lymphoid organ
- human lymphoid
- suppressive stromal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0651—Lymph nodes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0669—Bone marrow stromal cells; Whole bone marrow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261613697P | 2012-03-21 | 2012-03-21 | |
PCT/US2013/030802 WO2013142186A1 (en) | 2012-03-21 | 2013-03-13 | Isolation and use of human lymphoid organ-derived suppressive stromal cells |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1206277A1 true HK1206277A1 (en) | 2016-01-08 |
Family
ID=49223206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15107022.0A HK1206277A1 (en) | 2012-03-21 | 2015-07-23 | Isolation and use of human lymphoid organ-derived suppressive stromal cells |
Country Status (9)
Country | Link |
---|---|
US (2) | US10420801B2 (ko) |
EP (1) | EP2827879B1 (ko) |
JP (1) | JP6346602B2 (ko) |
KR (1) | KR102100307B1 (ko) |
CN (1) | CN104349785A (ko) |
AU (2) | AU2013235600B2 (ko) |
CA (1) | CA2867487C (ko) |
HK (1) | HK1206277A1 (ko) |
WO (1) | WO2013142186A1 (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6563379B2 (ja) * | 2013-03-15 | 2019-08-21 | ジャンセン ダイアグノスティックス,エルエルシー | 白血球の枯渇による循環腫瘍細胞の濃縮 |
FR3044325B1 (fr) * | 2015-12-01 | 2019-05-03 | Biomerieux | Procede d'evaluation du risque de complications chez les patients qui presentent un syndrome de reponse inflammatoire systemique (sirs) |
US20190367964A1 (en) * | 2016-02-02 | 2019-12-05 | Dana-Farber Cancer Institute, Inc. | Dissociation of human tumor to single cell suspension followed by biological analysis |
RU2770812C2 (ru) * | 2016-03-17 | 2022-04-22 | Ямагути Университи | Иммунокомпетентная клетка и экспрессирующий вектор, экспрессирующие регуляторные факторы иммунной функции |
US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
CN108715834B (zh) * | 2018-06-01 | 2021-09-14 | 天晴干细胞股份有限公司 | 一种富含cd41+、cd81+微囊的血小板裂解液制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE122010000049I1 (de) | 1997-04-15 | 2011-05-05 | Daiichi Sankyo Co Ltd | Neues protein und verfahren zu dessen herstellung |
AU782736B2 (en) * | 1999-10-25 | 2005-08-25 | Harbor Biosciences, Inc. | Therapeutic treatments for blood cell deficiencies |
AU5904101A (en) | 2000-04-05 | 2001-10-23 | Hyseq Inc | Methods and materials relating to novel stem cell growth factor-like polypeptides and polynucleotides |
GB0015426D0 (en) * | 2000-06-24 | 2000-08-16 | Univ Southampton | Method for generating soluble highly multimeric proteins |
AU2003233271A1 (en) * | 2002-06-14 | 2003-12-31 | Norwood Immunology Ltd | Thymic epithelial cells with progenitor capacity |
US20070027543A1 (en) | 2005-08-01 | 2007-02-01 | Gimble Jeffrey M | Use of adipose tissue-derived stromal cells in spinal fusion |
KR20080078204A (ko) | 2007-02-22 | 2008-08-27 | 크레아젠 주식회사 | 면역억제능이 증가된 간엽줄기세포-매개 자가유래수지상세포 |
US20100178700A1 (en) * | 2007-05-03 | 2010-07-15 | Australian Stem Cell Centre Ltd. | Novel thymic cellular populations and uses thereof |
JP2009273444A (ja) | 2008-05-19 | 2009-11-26 | Univ Of Tsukuba | 細胞培養支持体、その製造方法及び該支持体を用いた細胞培養方法 |
WO2010021993A1 (en) * | 2008-08-19 | 2010-02-25 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease |
US9388381B2 (en) * | 2009-07-09 | 2016-07-12 | Massachusetts Institute Of Technology | Methods and compositions for increased safety of stem cell-derived populations |
WO2011100532A1 (en) * | 2010-02-12 | 2011-08-18 | Abs Materials, Inc. | Sol-gel derived sorbent material containing a sorbate interactive material and method for using the same |
WO2013142255A2 (en) * | 2012-03-22 | 2013-09-26 | University Of Miami | Multi-specific binding agents |
-
2013
- 2013-03-13 US US14/386,535 patent/US10420801B2/en active Active
- 2013-03-13 WO PCT/US2013/030802 patent/WO2013142186A1/en active Application Filing
- 2013-03-13 CA CA2867487A patent/CA2867487C/en active Active
- 2013-03-13 KR KR1020147029325A patent/KR102100307B1/ko active IP Right Grant
- 2013-03-13 JP JP2015501751A patent/JP6346602B2/ja active Active
- 2013-03-13 CN CN201380025601.1A patent/CN104349785A/zh active Pending
- 2013-03-13 EP EP13764099.1A patent/EP2827879B1/en active Active
- 2013-03-13 AU AU2013235600A patent/AU2013235600B2/en active Active
-
2015
- 2015-07-23 HK HK15107022.0A patent/HK1206277A1/xx unknown
-
2018
- 2018-02-20 AU AU2018201195A patent/AU2018201195B2/en active Active
-
2019
- 2019-08-12 US US16/538,578 patent/US20200061118A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP6346602B2 (ja) | 2018-06-20 |
AU2013235600A1 (en) | 2014-10-02 |
WO2013142186A1 (en) | 2013-09-26 |
KR20140137444A (ko) | 2014-12-02 |
US20200061118A1 (en) | 2020-02-27 |
AU2018201195B2 (en) | 2020-04-16 |
CN104349785A (zh) | 2015-02-11 |
AU2018201195A1 (en) | 2018-03-08 |
CA2867487C (en) | 2021-02-02 |
EP2827879B1 (en) | 2019-05-08 |
US20150050298A1 (en) | 2015-02-19 |
EP2827879A4 (en) | 2015-11-04 |
CA2867487A1 (en) | 2013-09-26 |
EP2827879A1 (en) | 2015-01-28 |
JP2015512389A (ja) | 2015-04-27 |
US10420801B2 (en) | 2019-09-24 |
KR102100307B1 (ko) | 2020-04-14 |
AU2013235600B2 (en) | 2017-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181628T1 (hr) | Spojevi i postupci za njihovu upotrebu | |
HK1208439A1 (en) | 5-azaindazole compounds and methods of use 5- | |
ZA201501858B (en) | Anti-mcam antibodies and associated methods of use | |
EP2912178A4 (en) | SUPER AMPLIFIER AND METHOD FOR USE THEREOF | |
HK1206037A1 (en) | Human antibodies to gfr3 and methods of use thereof gfr3 | |
EP2938341A4 (en) | Heterocyclic compounds and methods for the use thereof | |
SI2806892T1 (sl) | Kombinirana terapevtska uporaba protiteles in endoglikozidaz | |
IL238227A0 (en) | Antibodies against c16orf54 and uses thereof | |
HK1206277A1 (en) | Isolation and use of human lymphoid organ-derived suppressive stromal cells | |
HK1208235A1 (en) | Anti-biotin antibodies and methods of use | |
IL233317A0 (en) | Anti-lrp5 antibodies and methods of use | |
HK1213490A1 (zh) | 免疫調節性小細胞及使用方法 | |
EP2804507A4 (en) | DEVICE FOR ENSURING TIGHT AND SMOOTH ADJUSTMENT OF A SHEET ON A MATTRESS | |
EP2938632A4 (en) | ANTI-GRANULYSIN ANTIBODIES AND METHODS OF USE | |
EP2836245A4 (en) | METHODS AND APPARATUS FOR ISOLATING WHITE GLOBLES | |
HK1209432A1 (en) | Anti-jagged antibodies and methods of use | |
HK1206249A1 (en) | Human autotaxin antibodies and methods of use (autotaxin) | |
EP2906576A4 (en) | GLYCOSPHINGOLIPIDES AND METHOD OF USE THEREOF | |
ZA201408128B (en) | Etract of greyia radlkoferi and use thereof | |
HK1212655A1 (zh) | 層壓設備和該層壓設備的使用 | |
EP2924046A4 (en) | NEW COMPLEX AND USE |